Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||Ft8,525.00|
|52 Week High||Ft6,280.00|
|52 Week Low||Ft9,320.00|
|1 Month Change||-2.63%|
|3 Month Change||3.65%|
|1 Year Change||26.58%|
|3 Year Change||59.35%|
|5 Year Change||41.14%|
|Change since IPO||4,636.11%|
Recent News & Updates
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s (BUSE:RICHTER) Intrinsic Value Is Potentially 99% Above Its Share Price
How far off is Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. ( BUSE:RICHTER ) from its intrinsic value? Using...
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Has A Pretty Healthy Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analyst Estimates: Here's What Brokers Think Of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) After Its First-Quarter Report
Last week, you might have seen that Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. ( BUSE:RICHTER ) released its...
|RICHTER||HU Pharmaceuticals||HU Market|
Return vs Industry: RICHTER exceeded the Hungarian Pharmaceuticals industry which returned 13.6% over the past year.
Return vs Market: RICHTER underperformed the Hungarian Market which returned 65.5% over the past year.
Stable Share Price: RICHTER is not significantly more volatile than the rest of Hungarian stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: RICHTER's weekly volatility (3%) has been stable over the past year.
About the Company
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company operates through two segments, Pharmaceuticals, and Wholesale and Retail.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Fundamentals Summary
|RICHTER fundamental statistics|
Is RICHTER overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|RICHTER income statement (TTM)|
|Cost of Revenue||Ft259.29b|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
Nov 08, 2021
|Earnings per share (EPS)||533.66|
|Net Profit Margin||16.94%|
How did RICHTER perform over the long term?See historical performance and comparison
2.6%Current Dividend Yield
Is Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: RICHTER (HUF8525) is trading below our estimate of fair value (HUF18219.26)
Significantly Below Fair Value: RICHTER is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: RICHTER is good value based on its PE Ratio (16x) compared to the European Pharmaceuticals industry average (26.2x).
PE vs Market: RICHTER is poor value based on its PE Ratio (16x) compared to the Hungarian market (15.4x).
Price to Earnings Growth Ratio
PEG Ratio: RICHTER is good value based on its PEG Ratio (0.8x)
Price to Book Ratio
PB vs Industry: RICHTER is good value based on its PB Ratio (1.9x) compared to the XE Pharmaceuticals industry average (3.4x).
How is Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RICHTER's forecast earnings growth (20.1% per year) is above the savings rate (1.2%).
Earnings vs Market: RICHTER's earnings (20.1% per year) are forecast to grow faster than the Hungarian market (4.9% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: RICHTER's revenue (7.9% per year) is forecast to grow faster than the Hungarian market (6.5% per year).
High Growth Revenue: RICHTER's revenue (7.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RICHTER's Return on Equity is forecast to be low in 3 years time (13.9%).
How has Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: RICHTER has high quality earnings.
Growing Profit Margin: RICHTER's current net profit margins (16.9%) are higher than last year (12.5%).
Past Earnings Growth Analysis
Earnings Trend: RICHTER's earnings have grown by 15.1% per year over the past 5 years.
Accelerating Growth: RICHTER's earnings growth over the past year (45.4%) exceeds its 5-year average (15.1% per year).
Earnings vs Industry: RICHTER earnings growth over the past year (45.4%) exceeded the Pharmaceuticals industry 10.2%.
Return on Equity
High ROE: RICHTER's Return on Equity (12.1%) is considered low.
How is Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's financial position?
Financial Position Analysis
Short Term Liabilities: RICHTER's short term assets (HUF369.0B) exceed its short term liabilities (HUF117.1B).
Long Term Liabilities: RICHTER's short term assets (HUF369.0B) exceed its long term liabilities (HUF96.7B).
Debt to Equity History and Analysis
Debt Level: RICHTER's debt to equity ratio (1.2%) is considered satisfactory.
Reducing Debt: RICHTER's debt to equity ratio has reduced from 6.4% to 1.2% over the past 5 years.
Debt Coverage: RICHTER's debt is well covered by operating cash flow (1197.3%).
Interest Coverage: RICHTER earns more interest than it pays, so coverage of interest payments is not a concern.
What is Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: RICHTER's dividend (2.64%) is higher than the bottom 25% of dividend payers in the Hungarian market (1.51%).
High Dividend: RICHTER's dividend (2.64%) is low compared to the top 25% of dividend payers in the Hungarian market (4.38%).
Stability and Growth of Payments
Stable Dividend: RICHTER's dividend payments have been volatile in the past 10 years.
Growing Dividend: RICHTER's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (42.3%), RICHTER's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: RICHTER's dividends in 3 years are forecast to be well covered by earnings (37.7% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Gábor Orbán (42 yo)
Mr. Gábor Orbán has been Chief Executive Officer of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. since November 1, 2017 and Member of Executive Board since September 05, 2016. Mr. Orbán served as...
Experienced Board: RICHTER's board of directors are considered experienced (4.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s employee growth, exchange listings and data sources
- Name: Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
- Ticker: RICHTER
- Exchange: BUSE
- Founded: 1901
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: Ft1.583t
- Shares outstanding: 185.64m
- Website: https://www.richter.hu
Number of Employees
- Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
- GyOemroi Ut 19-21.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/18 21:36|
|End of Day Share Price||2021/10/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.